Tim Van Assche

Systemic and Vascular Oxidation Limits the Efficacy of Oral Tetrahydrobiopterin Treatment in Patients With Coronary Artery Disease

Colin Cunnington, Tim Van Assche, Cheerag Shirodaria et al. · Circulation · 2012 · 161 citations · Full text

GCH1 Haplotype Determines Vascular and Plasma Biopterin Availability in Coronary Artery Disease

Charalambos Antoniades, Cheerag Shirodaria, Tim Van Assche et al. · Journal of the American College of Cardiology · 2008 · 78 citations · Full text

Metabolic Syndrome, Vascular Disease, Cardiovascular Disease +12

Pharmacological characterization of nucleotide P2Y receptors on endothelial cells of the mouse aorta

Pieter‐Jan Guns, András Korda, Herta Crauwels et al. · British Journal of Pharmacology · 2005 · 78 citations · Full text

Vascular Disease, Endothelial Cells, Vascular Tone +19

HMGCoA reductase inhibition reverses myocardial fibrosis and diastolic dysfunction through AMP-activated protein kinase activation in a mouse model of metabolic syndrome

Nerea Hermida, Andreas Markl, Julien Hamelet et al. · Cardiovascular Research · 2013 · 74 citations · Full text

First-in-Human Study in Healthy Subjects with FR104, a Pegylated Monoclonal Antibody Fragment Antagonist of CD28

Nicolas Poirier, Gilles Blancho, Maryvonne Hiance et al. · The Journal of Immunology · 2016 · 60 citations · Full text